Livforsakringsbolaget Skandia’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-400
| Closed | -$73.8K | – | 575 |
|
|
2024
Q4 | $73.8K | Hold |
400
| – | – | ﹤0.01% | 521 |
|
|
2024
Q3 | $78.8K | Buy |
+400
| New | +$78.8K | ﹤0.01% | 538 |
|
|
2023
Q4 | – | Sell |
-2,070
| Closed | -$406K | – | 578 |
|
|
2023
Q3 | $406K | Hold |
2,070
| – | – | 0.04% | 211 |
|
|
2023
Q2 | $435K | Hold |
2,070
| – | – | 0.05% | 217 |
|
|
2023
Q1 | $418K | Hold |
2,070
| – | – | 0.04% | 227 |
|
|
2022
Q4 | $451K | Hold |
2,070
| – | – | 0.05% | 220 |
|
|
2022
Q3 | $407K | Hold |
2,070
| – | – | 0.05% | 222 |
|
|
2022
Q2 | $443K | Hold |
2,070
| – | – | 0.04% | 244 |
|
|
2022
Q1 | $588K | Hold |
2,070
| – | – | 0.04% | 251 |
|
|
2021
Q4 | $780K | Buy |
2,070
+870
| +73% | +$328K | 0.05% | 231 |
|
|
2021
Q3 | $495K | Hold |
1,200
| – | – | 0.03% | 338 |
|
|
2021
Q2 | $444K | Buy |
+1,200
| New | +$444K | 0.03% | 373 |
|